We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.76B
AUM Growth
+$477M
Cap. Flow
+$295M
Cap. Flow %
10.72%
Top 10 Hldgs %
40.13%
Holding
124
New
45
Increased
34
Reduced
15
Closed
23

Top Buys

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$39.5M
2
ALKS icon
Alkermes
ALKS
+$38.6M
3
KO icon
Coca-Cola
KO
+$31.2M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$28.8M
5
ALT icon
Altimmune
ALT
+$28.7M

Top Sells

Rank Stock Value
1
DBX icon
Dropbox
DBX
+$35.4M
2
DG icon
Dollar General
DG
+$35.3M
3
BIIB icon
Biogen
BIIB
+$32.4M
4
ATR icon
AptarGroup
ATR
+$32.3M
5
BBY icon
Best Buy
BBY
+$29M

Sector Composition

Rank Sector Weight
1 Healthcare 48.21%
2 Consumer Discretionary 12.09%
3 Consumer Staples 9.81%
4 Industrials 2.38%
5 Technology 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$5.77B
$33.8M 1.23%
724,000
+224,000
+45% +$11M
ZYME icon
27
Zymeworks
ZYME
$1.68B
$33.4M 1.21%
716,000
-62,000
-8% -$2.13M
MDGL icon
28
Madrigal Pharmaceuticals
MDGL
$11.7B
$33M 1.2%
278,000
+30,000
+12% +$3.26M
KO icon
29
Coca-Cola
KO
$372B
$32M 1.16%
+648,000
New +$31.2M
AMZN icon
30
Amazon
AMZN
$2.99T
$31.2M 1.13%
198,460
-51,540
-21% -$8.13M
SPPI
31
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$30.9M 1.12%
+7,572,000
New +$28.8M
EPC icon
32
Edgewell Personal Care
EPC
$1.27B
$30.1M 1.09%
1,078,000
+378,000
+54% +$11.2M
KHC icon
33
Kraft Heinz
KHC
$31.6B
$29.9M 1.09%
1,000,000
+200,000
+25% +$6.66M
CPRX
34
DELISTED
Catalyst Pharmaceutical
CPRX
$29.7M 1.08%
10,000,000
+3,800,000
+61% +$14.9M
CVS icon
35
CVS Health
CVS
$134B
$29.2M 1.06%
500,000
+328,000
+191% +$20.4M
VYGR icon
36
Voyager Therapeutics
VYGR
$189M
$28.8M 1.05%
2,700,000
+622,000
+30% +$7.3M
EGRX
37
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$28.5M 1.04%
672,000
+390,000
+138% +$17.1M
BIIB icon
38
Biogen
BIIB
$29.8B
$28.4M 1.03%
100,000
-116,000
-54% -$32.4M
AVTA
39
DELISTED
Avantax, Inc. Common Stock
AVTA
$28.3M 1.03%
3,000,000
+952,000
+46% +$10.5M
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$27.9M 1.01%
168,000
-104,000
-38% -$14.2M
TWNK
41
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$26.2M 0.95%
2,124,000
-154,000
-7% -$1.94M
DKS icon
42
Dick's Sporting Goods
DKS
$18B
$24.3M 0.88%
+420,000
New +$20.4M
ENTA icon
43
Enanta Pharmaceuticals
ENTA
$377M
$24M 0.87%
524,000
+200,000
+62% +$9.69M
BNTX icon
44
BioNTech
BNTX
$23.3B
$23.3M 0.84%
+336,000
New +$24.1M
CL icon
45
Colgate-Palmolive
CL
$71.6B
$23.1M 0.84%
300,000
-68,000
-18% -$5.18M
MDLZ icon
46
Mondelez International
MDLZ
$79.2B
$22.8M 0.83%
396,000
-32,000
-7% -$1.78M
ARGX icon
47
argenx
ARGX
$52B
$22.3M 0.81%
85,000
+17,000
+25% +$4.09M
NUVA
48
DELISTED
NuVasive, Inc.
NUVA
$21.9M 0.79%
+450,000
New +$24.2M
DLTR icon
49
Dollar Tree
DLTR
$24.9B
$20.2M 0.73%
+220,747
New +$20.8M
ALT icon
50
Altimmune
ALT
$583M
$19M 0.69%
+1,436,000
New +$28.7M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Armistice Capital held 124 positions worth $2.76B, up 21% from $2.28B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $295M of net new capital in Q3 2020, opening 45 new positions and adding to 34 existing holdings. Its largest new stake was Williams-Sonoma: 890,000 shares worth $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Biogen, an estimated $32.4M trimmed.

  • Armistice Capital's largest Q3 2020 buy was Williams-Sonoma: 890,000 shares worth $40.2M.
  • Armistice Capital added most to AutoZone in Q3 2020, an estimated $27.5M increase.
  • Armistice Capital's biggest Q3 2020 reduction was Biogen, cutting an estimated $32.4M.
  • Armistice Capital fully exited Dropbox in Q3 2020, selling an estimated $35.4M.
  • Armistice Capital's ten largest holdings make up 40% of its $2.76B portfolio in Q3 2020.
  • Armistice Capital opened 45 new positions and closed 23 in Q3 2020.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $2.76B.

Based on Armistice Capital's 13F filing for Q3 2020, filed 16 Nov 2020.